"PanOncology Trials es un centro especializado en cáncer, ofreciendo tratamiento avanzados para pacientes luchando contra la enfermedad. Las terapias, visitas médicas, pruebas de laboratorios y radiografías relacionadas con el estudio clinico son libres de costo. Los patrocinadores de los estudios, primordiamente farmacéuticas y centros de investigación, cubren los costos asociados a las terapias. Nuestro equipo de investigadores y personal clínico tienen sobre 75 años de experiencia combinada realizando estudios clínicos de investigación."

During the past decade, Pan American Center for Oncology Trials, LLC conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pan American Center for Oncology Trials, LLC" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pan American Center for Oncology Trials, LLC" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pan American Center for Oncology Trials, LLC" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Adenomatous Polyposis Coli" (2 trials), "Sarcomatoid Renal Cell Carcinoma" (2 trials), "Stage IV Renal Cell Cancer AJCC v8" (2 trials) and "Advanced or Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Pan American Center for Oncology Trials, LLC" in a lesser frequency.

Most popular intervention types in "Pan American Center for Oncology Trials, LLC" are "Drug" (18 trials), "Biological" (7 trials), "Other" (5 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (6 trials), "Placebo" (6 trials), "Amivantamab" (4 trials), "Bevacizumab" (4 trials) and "Ipilimumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Pan American Center for Oncology Trials, LLC" are 18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pan American Center for Oncology Trials, LLC". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Pan American Center for Oncology Trials, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pan American Center for Oncology Trials, LLC, 5 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Pan American Center for Oncology Trials, LLC has several departments that took part in Clinical trials: "Pan American Center for Oncology Trials (PanOncology Trials)" - 4 trials